Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
NCT03201978
A Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of GSK2894512 in Healthy Adult Subjects
Phase: Phase 1
Role: Collaborator
Start: Dec 14, 2017
Completion: May 15, 2018